Back to today’s briefing

Story perspectives

Strategas Head Jason Trennert Battling Cancer, Remains Optimistic

1/18/2026

23 3

Summary

Story summary

Jason Trennert, the head of Strategas Research Partners, is battling blood cancer but remains optimistic.
After severe migraines, he was diagnosed and underwent chemotherapy and stem cell therapy, leaving him weakened.
He has returned to work and financial media appearances.
He is currently seeking a kidney donor.
He is known for contrarian views and predicted the success of U.S. President Donald Trump's policies, while criticizing Biden's spending.

1 of 1

Story summary

Jason Trennert, the head of Strategas Research Partners, is battling blood cancer but remains optimistic.
After severe migraines, he was diagnosed and underwent chemotherapy and stem cell therapy, leaving him weakened.
He has returned to work and financial media appearances.
He is currently seeking a kidney donor.
He is known for contrarian views and predicted the success of U.S. President Donald Trump's policies, while criticizing Biden's spending.